BOSTON, May 08, 2025 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today ...

Millicom International Cellular S.A. (NASDAQ: TIGO), a leading telecommunications provider in Latin America, reported first quarter 2025 revenue that fel ...

Rachid Meziane finished up another practice Wednesday, neither overjoyed nor overly concerned. This is going to be a process, to make the kind of basketball he knows ...

Three former Memphis officers were acquitted Wednesday of state charges, including second-degree murder, in the fatal beating ...

Getting a larger share of a business that you like is always something that you would take a look at,” he said. “We have ...

Company remains on track to submit NDA for bitopertin in erythropoietic protoporphyria (EPP) in H2 2025Initiated APOLLO, a confirmatory clinical trial of bitopertin in adults and adolescents with EPPP ...

The Herald Review, is collaborating with First Call for Help, the Crisis Response Team, Itasca County Health and Human Services, and the Itasca County Sheriff’s Office to help educate, inform, ...

Initiated APOLLO, a double-blind, placebo-controlled, confirmatory trial of bitopertin in adults and adolescents with EPP.